Market Trends– category –
-
Semaglutide More Than Doubles MASH Resolution Likelihood in Meta-Analysis, Stabilizing Fibrosis
AJMC USA Overview A systematic review and meta-analysis published in Medicine reveals that the GLP-1 receptor agonist semaglutide more than doubles the likelihood of MASH (metabolic dysfunction-associated steatohepatitis) resolution with... -
EMA Recommends Approval for New Hypercholesterolemia Drug Evlarco (Obicetrapib / Ezetimibe): A Combination of CETP Inhibitor and Cholesterol Absorption Inhibitor
EMA EU Overview On July 23, 2026, the EMA's CHMP adopted a positive opinion recommending marketing authorization for Evlarco (obicetrapib / ezetimibe). This oral medication is for the treatment of primary hypercholesterolemia or mixed dy... -
First Half 2026 Sees 24 New Small-Molecule Approvals: Pioneering PROTAC Vepdegestrant and Oral GLP-1 Orforglipron Enter Market
Chemexpress China Overview Twenty-four small-molecule drugs received their first global approval in the first half of 2026, with 95.8% being oral dosage forms. Key highlights include the approval of the first commercial PROTAC, vepdegest... -
Daiichi Sankyo & AstraZeneca’s Enhertu Plus Pertuzumab Recommended for EU Approval as 1st-Line Treatment for HER2-Positive Metastatic Breast Cancer, Achieves 44% Risk Reduction in Phase III
Daiichi Sankyo Press Release Japan Overview The EMA's CHMP has recommended Enhertu (trastuzumab deruxtecan) in combination with pertuzumab for approval as a first-line treatment for HER2-positive metastatic breast cancer in the EU. This ... -
Daiichi Sankyo’s Early ADC Pipeline Lags Rivals as Cash Flow Nears Peak, Incurs $850M Charges for Underutilized CMO Capacity
BioSpace USA Overview Jefferies analysts suggest Daiichi Sankyo's early-stage antibody-drug conjugate (ADC) pipeline is not keeping pace with rivals, despite the success of Enhertu and Datroway. Enhertu and Datroway are nearing peak reve... -
Biopharmaceuticals Contract Manufacturing Market Expands Amid Global Demand: CDMOs Scale Up Capacity
openPR.com Unknown Overview This article provides an overview of a market research report published by openPR.com. The biopharmaceutical contract manufacturing market is growing due to increased demand for biosimilars, expanded investmen... -
European EV Demand and US BESS Drive LG Energy Solution’s Q2 Profit Turnaround, Solid-State Battery Pilot Line Forthcoming
Energy-Storage.news South Korea Overview LG Energy Solution returned to profitability in Q2 2026, attributing its success to increased EV cell demand in Europe and robust Battery Energy Storage System (BESS) sales in the U.S. The company... -
U.S. Government Invests Heavily in Domestic Battery Production and Recycling to Fortify National Security
RealClearDefense USA Overview The U.S. is expanding federal funding for domestic battery production, recycling, and manufacturing, with a strong focus on critical minerals and supply chain resilience. The Department of Energy (DOE) has c... -
Sila Nanotechnologies Private Stock Reaches $2.33 Billion Valuation on Forge Global
Forge Global USA Overview Sila Nanotechnologies, a privately held next-generation battery materials developer, recorded a Forge Price of $16.42 per share as of July 31, 2026, valuing the company at $2.33 billion. The company has cumulati... -
Toyota’s 745-Mile Solid-State Battery Demonstrates Range and Safety Advantages Over Honda’s Technology
Top Speed USA Overview Toyota's all-solid-state battery is projected to overcome existing EV limitations, theoretically offering a 745-mile (approx. 1,200 km) range, rapid charging capability, and robust performance across extreme temper...
